SCHEMBL4693030

SCHEMBL4693030

O=C1C(Cc2ccccc2)c2cc(O)ccc2N1c1cc(Cl)cc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
EP300 Q09472 1/20 0.39
ALOX5 P09917 2/20 0.39
ITGB2 P05107 1/20 0.39
ICAM1 P05362 1/20 0.39
ITGAL P20701 1/20 0.39
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.37
MMP2 P08253 2/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KIF11 P52732 2/20 0.35
CES2 O00748 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4687956 0.86 ALOX5 (0.50) GAAEP300ALOX5ITGB2ICAM1
SCHEMBL4690051 0.82 ALOX5 (0.46) ALOX5ITGB2ICAM1ITGALMEN1
SCHEMBL4687618 0.78 ITGB2 (0.41) GAAEP300ALOX5ITGB2ICAM1
SCHEMBL4692248 0.78 ALOX5 (0.47) ALOX5ITGB2ICAM1ITGALCES2
SCHEMBL4690047 0.75 ITGAL (0.40) ALOX5ITGB2ICAM1ITGALCES2
SCHEMBL4688597 0.71 ALOX5 (0.48) ALOX5ITGB2ICAM1ITGALMEN1
SCHEMBL4692140 0.70 ITGAL (0.38) ALOX5ITGB2ICAM1ITGALCES2
SCHEMBL4687837 0.69 ITGAL (0.40) GAAALOX5ITGB2ICAM1ITGAL
SCHEMBL29158505 0.68 ALDH1A1 (0.55) GAAALOX5MEN1ALDH1A1KMT2A
SCHEMBL4689907 0.68 ITGAL (0.36) ALOX5ITGB2ICAM1ITGALMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399155-B1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMA (US) 2008-05-28 EP claimed
US-6414153-B1 TREATMENT OF INFLAMMATORY OR IMMUNE CELL-MEDIATED DISEASE OR CONDITION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-07-02 US claimed
EP-1399155-B1 SMALL MOLECULES USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASE BOEHRINGER INGELHEIM PHARMA (US) 2008-05-28 EP disclosed
US-6414153-B1 TREATMENT OF INFLAMMATORY OR IMMUNE CELL-MEDIATED DISEASE OR CONDITION BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-07-02 US disclosed